본문 바로가기

Drug holiday patterns and bisphosphonate-related osteonecrosis of the jaw

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q1
저널
ORAL DISEASES25(2) · pp.471 · 2019
피인용
Web of Science 22Scopus 24
FWCI (Scopus)
2.46
JCR IF
JCR 2018 2.625
ISSN
1354-523X

저자

  1. Jung, Sun-Young제1저자College of Pharmacy, Chung-Ang University, Seoul, South Korea
  2. 서혜선College of Pharmacy, Pusan National University, Pusan, South Korea
  3. Park, Ji-WonCollege of Natural Science, Kyungpook National University, Daegu, South Korea
  4. Kwon, Jin-Won교신저자College of Natural Science, Kyungpook National University, Daegu, South Korea

초록

Objectives There is limited evidence regarding the appropriate length of a bisphosphonate (BP) holiday to reduce the risk of osteonecrosis of the jaw (ONJ). In this cross-sectional study, we investigated the population-based patterns of the gaps between BP discontinuation and ONJ diagnosis. Subjects and Methods We used the claims database of the National Health Insurance Service in Korea. Among BP users between 2006 and 2015, incident ONJ cases during 2010-2015 with no history of ONJ in the last 4 years were identified. We assessed the time gap from the last BP administration to ONJ diagnosis. Results Among 1,569 incident ONJ cases, 836 (53.3%) occurred after BP discontinuation. The cumulative proportions of ONJ occurrence within 1 month, 3 months, 1 year, 2 years, and 3 years after discontinuation were 58.9%, 70.8%, 87.0%, 93.2%, and 96.1%, respectively. The length of drug holidays showed no significant difference between patients with or without comorbid cancer and diabetes mellitus (p-value, 0.12 and 0.52, respectively). However, the use of injectable BP formulations significantly affected ONJ incidence (p < 0.01). Conclusions Most ONJ cases occurred within 3 years from BP suspension, with a higher prevalence among BP injection users with 1 year or lesser BP holiday.

키워드

adverse reactionsalveolar bone lossbisphosphonatedrug therapyosteonecrosis of the jawpharmacoepidemiologyMEDICATION-RELATED OSTEONECROSISSURGEONS POSITION PAPERCANCER-PATIENTSRISK-FACTORSAMERICAN ASSOCIATIONPROSTATE-CANCERBONEEPIDEMIOLOGYALENDRONATEMETASTASES

식별자

Scopus EID
2-s2.0-85053443846
WoS UID
000458899300013